DEMENTIA FRONTOTEMPORAL
Clinical trials for DEMENTIA FRONTOTEMPORAL explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA FRONTOTEMPORAL trials appear
Sign up with your email to follow new studies for DEMENTIA FRONTOTEMPORAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy could slow genetic dementia – first human trial underway
Disease control Recruiting nowThis study tests a new gene therapy called AVB-101 for people with a genetic form of frontotemporal dementia (FTD-GRN). The treatment is given once, directly into the brain, to restore a missing protein and potentially slow or stop the disease. About 18 adults aged 30-75 with ear…
Matched conditions: DEMENTIA FRONTOTEMPORAL
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Can two languages shield the brain? new study targets bilingual aphasia
Knowledge-focused Recruiting nowThis study looks at whether being bilingual helps people with primary progressive aphasia (PPA) respond better to speech therapy. Researchers will give tailored language treatment in both languages to 60 bilingual Spanish speakers and track their progress for a year. Another 30 p…
Matched conditions: DEMENTIA FRONTOTEMPORAL
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC